Application of reproductive hormone peptides for tumor targeting

Area of Science:

• Oncology
• Endocrinology
• Pharmacology

Background:

• Targeted cancer therapy aims to improve drug efficacy and minimize side effects through high selectivity.
• Utilizing tumor-specific ligands and receptors is a key strategy for delivering antitumor agents.
• Reproductive hormone receptors, with limited normal tissue distribution, offer potential as targeted sites for cancer treatment.

Purpose of the Study:

• To review targeted antitumor therapeutic strategies employing reproductive hormone peptides and their receptors.
• To discuss the application of gonadotropin-releasing hormone, follicle-stimulating hormone, luteinizing hormone, and human chorionic gonadotropin in targeted cancer therapy.

Main Methods:

• Literature review of existing research on targeted cancer therapy using reproductive hormones.
• Analysis of strategies involving peptide ligands and their corresponding receptors for tumor targeting.
• Examination of approaches that have progressed to clinical trials.

Main Results:

• Various tumor targeting approaches using reproductive hormone peptides have been developed.
• Some of these targeted strategies have advanced into clinical trials, demonstrating feasibility.
• The selectivity of reproductive hormone receptors allows for targeted drug delivery to cancer cells.

Conclusions:

• Targeted therapy using reproductive hormone peptides and their receptors presents a promising strategy for cancer treatment.
• The high selectivity of these systems enhances antitumor agent efficacy while reducing systemic toxicity.
• Further development and clinical investigation of these approaches are warranted.